06998 嘉和生物-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
03/09/2025郭峰1303(L)1,590,721(L)21,158,108(L)4.02
24/07/2025HHJH Holdings Limited1213(L)126,239,103(L)23.99
24/07/2025郭峰1303(L)805,875(L)21,158,108(L)4.02
24/07/2025Hillhouse Fund IV, L.P.1213(L)126,239,103(L)23.99
24/07/2025HH BIO Investment Fund, L.P.1213(L)126,239,103(L)23.99
29/05/2025郭峰1303(L)488,167(L)21,158,108(L)4.03
28/05/2025郭峰1303(L)1,263,375(L)21,158,108(L)4.04
27/05/2025郭峰1303(L)2,905,830(L)21,158,108(L)4.04
20/11/2024翁承毅1303(L)35,000(L)1,530,000(L)0.29
20/11/2024翁承毅1711(L)1,522,500(L)1,522,500(L)0.29
07/10/2024DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH1013(L)+153,448,981(L)153,448,981(L)6.55
07/10/2024FNOF GP Limited1013(L)+153,448,981(L)153,448,981(L)6.55
07/10/2024Forebright New Opportunities Fund, L.P.1013(L)+153,448,981(L)153,448,981(L)6.55
07/10/2024FORBRIGHT GLOBAL LIMITED1013(L)+153,448,981(L)153,448,981(L)6.55
07/10/2024FNOF GP Limited1013(L)+153,448,981(L)153,448,981(L)6.55
04/10/2024Boundless Plain Holdings Limited1001(L)+155,485,499(L)155,485,499(L)29.90
04/10/2024李浩良1001(L)+155,485,499(L)155,485,499(L)29.90
04/10/2024倪昕1013(L)+880,301,348(L)880,301,348(L)169.30
04/10/2024Skycus China Fund, L.P.1001(L)+155,485,499(L)155,485,499(L)29.90
12/09/2024翁承毅1705(L)1,530,000(L)1,530,000(L)0.29
11/09/2024Temasek Holdings (Private) Limited1213(L)31,157,348(L)5.99
03/09/2024郭峰1303(L)1,052,500(L)21,158,108(L)4.10
10/04/2024郭峰1303(L)4,442,416(L)21,158,108(L)4.13
10/04/2024Hillhouse Investment Management, Ltd.1213(L)127,989,103(L)24.97
27/10/2023郭峰11031(L)+9,789,054(L)21,158,108(L)4.17
 1  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.